Journals 2023
Publications menu
        BopN is a Gatekeeper of the Bordetella Type III Secretion System.        
                  Microbiology Spectrum.                
                  2023,
                
                              11(3),
                  
                              e0411222,
                          
                  ISSN: 2165-0497,
                
                
                              PMID: 37036369,                          
                
                          
        
      
    
        Metal Nanoparticles with Antimicrobial Properties: The Toxicity Response in Mouse Mesenchymal Stem Cells.        
                  Toxics.                
                  2023,
                
                              11(3),
                  
                              253,
                          
                  ISSN: 2305-6304,
                
                
                              PMID: 36977018,                          
                
                          
        
      
    
        A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022).        
                  Expert Opinion on Therapeutic Patents.                
                  2023,
                
                              33(2),
                  
                              67-87,
                          
                  ISSN: 1354-3776,
                
                
                              PMID: 36975020,                          
                
                          
        
      
    
        Immunohistochemical evaluation of tissues following bone implant extraction from upper and lower limb.        
                  Histology and Histopathology.                
                  2023,
                
                          
                                  
                  ISSN: 0213-3911,
                
                
                              PMID: 36928509,                          
                
                          
        
      
    
        Anticancer effect of zanubrutinib in HER2-positive breast cancer cell lines.        
                  Investigational New Drugs.                
                  2023,
                
                              41(2),
                  
                              210-219,
                          
                  ISSN: 0167-6997,
                
                
                              PMID: 36913160,